SOURCES SOUGHT
A -- Toxicological Evaluation of Potential Medications to Reduce Drug Use
- Notice Date
- 1/14/2003
- Notice Type
- Sources Sought
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Blvd. Room #3105, Bethesda, MD, 20892-9543
- ZIP Code
- 20892-9543
- Solicitation Number
- Reference-Number-NIDA-38841
- Archive Date
- 3/12/2003
- Point of Contact
- Kenneth Goodling, Contracting Officer, Phone (301)443-6677, Fax (301)443-7595,
- E-Mail Address
-
kg25d@nih.gov
- Small Business Set-Aside
- Total Small Business
- Description
- The National Institute on Drug Abuse (NIDA) seeks capability statements from qualified Small Businesses (NAICS 541710, small business size standard is 500 employees). Offerors must conduct preclinical toxicology studies that support the development of pharmacotherapies as medications. The preclinical studies shall adhere to Good Laboratory Practices (GLP) guidelines as set forth by relevant Food and Drug Administration (FDA) guidance and regulations (e.g. CFR Title 21). Offerors must have on-site in vivo toxicology testing facilities and access to state-of-the-art equipment for analytical testing of dosing solutions and verification of identity of the bulk substance (HPLC, GC/LC-MS, IR and NMR). Offerors must show experience in preparing reports acceptable in format for submission to the FDA. To handle test substances under the Controlled Substances Act of 1970, offerors must possess a DEA Registration for Schedules II to V. NIDA may also require a Schedule I DEA research registration. Information sent should be relevant and specific in the technical area under consideration, on each of the following qualifications: (1) Experience: An outline of previous projects, specific GLP work performed and any in-house research and development effort; (2) Personnel: Name, professional qualifications and specific experience of scientists and technical personnel who may be assigned as principal investigator and/or project director; (3) Facilities: Availability and description of special facilities required to perform toxicological studies that support the development of potential pharmacotherapies for the reduction of substance abuse. Any other specific and relevant information about this particular area of procurement that would improve our consideration and evaluation of the information presented is desirable. Interested organizations must demonstrate and document, in any capability statements submitted, extensive experience with and the ability to perform the above tasks. Organizations should demonstrate capability to administer and coordinate interrelated tasks in an effective and timely manner. Documentation may include, but not be limited to, contracts both Government and commercial the organization performed, references, i.e., names, titles, telephone numbers and any other information serving to document the organizations capability, e.g., awards, commendations, etc. This notice is for information and planning purposes only and does not commit the Government to any contractual agreement. This is not a request for proposals. The Government does not intend to award a contract based on responses under this announcement nor otherwise pay for preparing any information sent or the Government's use of the information. Any proprietary information should be so marked. Interested organizations presenting a capability statement in response to this sources sought announcement must identify their size status. Offerors must send written capability statements by February 25 to the NIDA Contracting Officer at: If using U.S. Postal Service - National Institute on Drug Abuse, NIH, Contracts Management Branch, OPRM, 6001 Executive Boulevard, Room 3105, MSC 9543, Bethesda, Maryland 20892-9543 OR, if hand-delivered or delivery service - National Institute on Drug Abuse, NIH, Contracts Management Branch, OPRM, 6001 Executive Boulevard, Room 3105, Rockville, Maryland 20852
- Record
- SN00238905-W 20030116/030114213701 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |